Puma Biotechnology, Inc.’s (PBYI) witnessed a gain of 0.14% in recent trading period with closing price of $ 36.50. The
Archives
The BioAmber Inc. (BIOA) Upgrade by the Zacks Investment Research
According to Zacks, âBioAmber Inc. is a bio-based chemicals company. It produces and sells bio-succinic acid. The company’s technology platform …
The Lion Biotechnologies Inc. Expected to Earn FY2018 Earnings of ($1.09) Per Share (LBIO)
Lion Biotechnologies Inc. (NASDAQ:LBIO) â FBR & Co issued their FY2018 earnings estimates for shares of Lion Biotechnologies in a
Biotechnology Industry News- The future of the global stem cell umbilical cord blood market seems …
Umbilical cord blood (UCB) stem cells have gained much significance in medical science owing to their ability to transform into
Biotech ETFs: A Short-Lived Boon From Biogen
Biogen’s initial share price surge helped to lift the bio biotech exchange-traded funds at a clip that dramatically outpaced the
Market Runner: What’s Next for Bioamber Inc After Today’s Huge Decline?
It produces and sells bio-succinic acid. The company’s technology platform combines industrial biotechnology and chemical catalysis to convert …
Victory Capital Management Inc. Buys New Position in Lion Biotechnologies Inc. (LBIO)
Lion Biotechnologies logo Victory Capital Management Inc. bought a new position in shares of Lion Biotechnologies Inc. (NASDAQ:LBIO) during the …
Value Composite Score Update on Puma Biotechnology, Inc. (NYSE:PBYI)
In looking at the Value Composite score for Puma Biotechnology, Inc. (NYSE:PBYI), we see that the firm has a rank
Biotech news that matter for investors: Sangamo BioSciences, Inc. (NASDAQ:SGMO), Puma …
Puma Biotechnology, Inc. (NYSE:PBYI) shares closed at $36.45, down -3.35 points or -8.42 percent from the previous close price. The
A look at how Texas is advancing in medicine and biotechnology
The Texas business journals in Dallas, San Antonio, Houston and Austin are proud to bring you our inaugural edition of